Noticias de Eulerpool Newron Pharmaceuticals SpA

Newron Pharmaceuticals SpA Noticias de Acciones

Newron Pharmaceuticals SpA es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Newron Pharmaceuticals SpA.

• 12 de mayo ·

  Yahoo
  Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS)
• 24 de marzo ·

  Yahoo
  Newron proposes renowned biopharma company founder and entrepreneur Dr. Chris Martin for election as Independent Chairman
• 9 de enero ·

  Yahoo
  Newron and Myung In Pharm Announce License Agreement for evenamide in South Korea
• 13 de diciembre ·

  Yahoo
  Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
• 8 de agosto ·

  Yahoo
  Aligos Therapeutics Strengthens Board with Two New Independent Directors
• 18 de junio ·

  Yahoo
  Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City